Kimberly Sharp

Experience:

30 Years

Specialized In:

Oral, Breast, & Brain Cancers

Description:

Kimberly Sharp is the Chief Executive Officer of Keraceuticals, a next-generation pharmaceutical company pioneering novel therapeutics like CIDD-99, a targeted calcium inhibitor showing promising preclinical results against oral, breast, and brain cancers. A proven leader in both the financial and life sciences sectors, Kimberly brings over 30 years of experience in investment banking, capital strategy, and venture development to her role as CEO. Prior to founding Keraceuticals, Kimberly led a distinguished career in wealth management and investment banking. At Wells Fargo Advisors, she co-founded and scaled a $1.7 billion wealth management practice focused on ultra-high-net-worth families, celebrities, and professional athletes. Recognized by Barron's and Forbes as a top advisor, she specialized in alternative investments, private placements, and multi-generational wealth strategy.

Working days:

Tuesday, Wednesday, Saturday

Explore My Expertise :

Kimberly has executed complex capital raises, mergers and acquisitions, and fund structuring initiatives across healthcare, technology, consumer goods, and real estate. Her capital markets acumen includes deep expertise in valuation modeling, capital stack optimization, exit strategy planning, and liquidity event execution—skills she now applies to scaling Keraceuticals from the lab to market.

She also serves as Chief Capital Officer at Thinkhat Venture Studios, where she leads capital formation, fund deployment, and investor relations for a portfolio of cutting-edge biotech and health tech companies. In this role, she has guided numerous startups through funding rounds, M&A discussions, and go-to-market planning. As founder of Think Sharp Creative, Kimberly has advised founders and CEOs on positioning their companies for rapid growth and successful exits. Her strategic leadership recently doubled the valuation of a MedTech company in less than a year.

A trusted advisor to boards and C-suites, Kimberly blends operational execution with investor strategy to drive enterprise value. She is a certified EOS™ Implementor, aligning leadership teams through disciplined growth frameworks, and holds Series 7, 63, and 65 licenses.